Noxopharm Limited (NOX.AX)
AUD 0.09
(-1.06%)
AUD 0.09
(-1.06%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 2.4 Million AUD | -60.06% |
| 2023 | 6.01 Million AUD | 10.71% |
| 2022 | 5.42 Million AUD | -3.2% |
| 2021 | 5.6 Million AUD | -32.29% |
| 2020 | 8.28 Million AUD | 120.82% |
| 2019 | 3.75 Million AUD | 309.22% |
| 2018 | 916.53 Thousand AUD | 625.69% |
| 2017 | 126.29 Thousand AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q4 | 1.18 Million AUD | 0.0% |
| 2024 Q2 | 1.21 Million AUD | 0.0% |
| 2023 Q2 | 3.34 Million AUD | 0.0% |
| 2023 Q4 | 2.66 Million AUD | 0.0% |
| 2023 FY | 6.01 Million AUD | 10.71% |
| 2022 FY | 5.42 Million AUD | -3.2% |
| 2022 Q2 | 1.78 Million AUD | 0.0% |
| 2022 Q4 | 3.63 Million AUD | 0.0% |
| 2021 Q2 | 1.35 Million AUD | 0.0% |
| 2021 FY | 5.6 Million AUD | -32.29% |
| 2021 Q4 | 4.25 Million AUD | 0.0% |
| 2020 Q2 | 3.76 Million AUD | 0.0% |
| 2020 FY | 8.28 Million AUD | 120.82% |
| 2020 Q4 | 4.52 Million AUD | 0.0% |
| 2019 Q4 | 486.33 Thousand AUD | 0.0% |
| 2019 FY | 3.75 Million AUD | 309.22% |
| 2019 Q2 | 3.26 Million AUD | 0.0% |
| 2018 Q4 | 61.01 Thousand AUD | 0.0% |
| 2018 FY | 916.53 Thousand AUD | 625.69% |
| 2018 Q2 | 855.51 Thousand AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 FY | 126.29 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 126.29 Thousand AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 96.387% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -2427.884% |
| Biome Australia Limited | 13 Million AUD | 81.549% |
| Patrys Limited | 1.39 Million AUD | -72.166% |
| Orthocell Limited | 5.31 Million AUD | 54.843% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 22.05 Million AUD | 89.119% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 67.815% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 35.344% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -169.046% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -3.655% |
| CSL Limited | 22.41 Billion AUD | 99.989% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -14019.271% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -13001.943% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 97.278% |
| Starpharma Holdings Limited | 8.28 Million AUD | 71.043% |
| Nanollose Limited | 12.5 Thousand AUD | -19100.672% |
| Memphasys Limited | 60 Thousand AUD | -3900.46% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -98.001% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 46.094% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -298.836% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -91.78% |
| Race Oncology Limited | 4 Million AUD | 40.045% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.517% |
| Dimerix Limited | 583.47 Thousand AUD | -311.374% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 31.533% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 79.14% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 40.281% |
| BTC Health Limited | 16.36 Thousand AUD | -14571.614% |
| Acrux Limited | 5.09 Million AUD | 52.853% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 98.965% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -1476.64% |
| AdAlta Limited | 1.73 Million AUD | -38.122% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -702.156% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -421.349% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -3547.836% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -406.867% |
| Actinogen Medical Limited | 9.93 Million AUD | 75.832% |
| Immuron Limited | 4.9 Million AUD | 51.043% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 7.608% |